Legal Representation
Attorney
Keum J. Park
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 21, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 2, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 2, 2002 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 4, 2002 | I | PAPER RECEIVED | Loading... | |
| Dec 2, 2002 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 4, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 11, 2002 | I | PAPER RECEIVED | Loading... | |
| Mar 12, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 20, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 1, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 20, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 20, 2000 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Oct 12, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Other
The stippling is a feature of the mark to effect shading, as permitted under TMEP 807.06(d), and is not intended to indicate color.
Classification
International Classes
005